Amir Taherkhani
Overview
Explore the profile of Amir Taherkhani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
846
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bahrambanan F, Alizamir M, Moradveisi K, Heddam S, Kim S, Kim S, et al.
Sci Rep
. 2025 Jan;
15(1):62.
PMID: 39748016
Colorectal cancer (CRC) is a form of cancer that impacts both the rectum and colon. Typically, it begins with a small abnormal growth known as a polyp, which can either...
2.
Ahmadi M, Barkhoda N, Alizamir A, Taherkhani A
Int J Breast Cancer
. 2024 Oct;
2024:8796102.
PMID: 39473450
Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options. This study is aimed at identifying potential therapeutic targets in TNBC using gene regulatory network analysis and a...
3.
Salman M, Asgartooran B, Taherkhani A
Int J Dent
. 2024 Oct;
2024:9970824.
PMID: 39411079
Dental caries, a prevalent infectious disease affecting teeth, ranks highest among 328 diseases, according to a 2017 Lancet study. In demineralized human dentin, matrix metalloproteinase-3 (MMP3) functions as a proteoglycanase,...
4.
Jamshidi S, Tavangar M, Shojaei S, Taherkhani A
Anal Cell Pathol (Amst)
. 2024 Oct;
2024:6260651.
PMID: 39376501
Oral squamous cell carcinoma (OSCC) is a prevalent and aggressive form of head and neck cancer, often diagnosed at advanced stages. Elucidating the molecular mechanisms involved in the malignant transformation...
5.
Arabestani M, Saadat M, Taherkhani A
Genomics Inform
. 2024 Sep;
22(1):13.
PMID: 39232833
Objective: Antibiotic resistance poses a pressing and crucial global public health challenge, leading to significant clinical and health-related consequences. Substantial evidence highlights the pivotal involvement of rifampicin monooxygenase (RIFMO) in...
6.
Ahmadi M, Abdollahi R, Otogara M, Taherkhani A
Genomics Inform
. 2024 Jun;
22(1):9.
PMID: 38926832
Objective: Cervical cancer (CxCa) stands as a significant global health challenge, ranking fourth in cancer-related mortality among the female population. While chemotherapy regimens have demonstrated incremental progress in extending overall...
7.
Vaziri-Amjad S, Rahgosha R, Taherkhani A
Evid Based Complement Alternat Med
. 2024 May;
2024:1114928.
PMID: 38706884
Background: Janus-activated kinase 2 (JAK2) plays a pivotal role in numerous essential biological processes, including proliferation, apoptosis, and metastasis in human cells. Prior studies have indicated that inhibiting JAK2 could...
8.
Shirizadeh A, Borzouei S, Razavi Z, Taherkhani A, Faradmal J, Solgi G
Immunogenetics
. 2024 Apr;
76(3):175-187.
PMID: 38607388
One of the probable hypotheses for the onset of autoimmunity is molecular mimicry. This study aimed to determine the HLA-II risk alleles for developing Hashimoto's thyroiditis (HT) in order to...
9.
Amini R, Moradi S, Najafi R, Mazdeh M, Taherkhani A
Oxid Med Cell Longev
. 2024 Mar;
2024:6654606.
PMID: 38425997
Background: Neurological disorders like Alzheimer's disease (AD) and Parkinson's disease (PD) manifest through gradually deteriorating cognitive functions. An encouraging strategy for addressing these disorders involves the inhibition of precursor-cleaving enzyme...
10.
Bayat Z, Mazaheri T, Farhadifard H, Taherkhani A
Biomed Res Int
. 2024 Feb;
2024:1236910.
PMID: 38322303
Objective: Oral squamous cell carcinoma (OSCC) is the most frequent oral cancer, constituting more than 90% of all oral carcinomas. The 5-year survival rate of OSCC patients is not satisfactory,...